Anavex Life Sciences Corp (AVXL)

[Mygolfballs]

CEO Missling SEC debacle Stock Promotion, Not Drug Development, Was Priority No. 1

By Adam Feuerstein Apr 11, 2017

In February 2014, Anavex, run by CEO Chris Missling, paid $5,500 to CSIR Group for three stock-promoting articles, charged the SEC. Within days, an individual with CSIR emailed an Anavex executive with a draft article, stating, "It's about 2200 words and we focus on Anavex in the second half. Important not to be too obvious about our focus on Anavex because [Seeking Alpha] will reject it because the stock is small." When the article was published, Anavex's payment was not disclosed, according to the SEC.

The SEC did not charge Missling in the stock promotion enforcement action. An Anavex spokesman did not respond to email seeking comment

.

It just keeps getting better